Show simple item record

The pathology of malabsorption: current concepts

dc.contributor.authorOwens, S. R.en_US
dc.contributor.authorGreenson, Joel K.en_US
dc.date.accessioned2010-06-01T21:23:55Z
dc.date.available2010-06-01T21:23:55Z
dc.date.issued2007-01en_US
dc.identifier.citationOwens, S R; Greenson, J K (2007). "The pathology of malabsorption: current concepts." Histopathology 50(1): 64-82. <http://hdl.handle.net/2027.42/74460>en_US
dc.identifier.issn0309-0167en_US
dc.identifier.issn1365-2559en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74460
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17204022&dopt=citationen_US
dc.format.extent1764127 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Authors. Journal compilation 2007 Blackwell Publishing Limited.en_US
dc.subject.otherAutoimmune Enteropathyen_US
dc.subject.otherBacterial Overgrowthen_US
dc.subject.otherCoeliac Diseaseen_US
dc.subject.otherGiardiasisen_US
dc.subject.otherGluten-sensitive Enteropathyen_US
dc.subject.otherMalabsorptionen_US
dc.subject.otherSprueen_US
dc.subject.otherWhipple's Diseaseen_US
dc.titleThe pathology of malabsorption: current conceptsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Health System, Ann Arbor, MI, USAen_US
dc.identifier.pmid17204022en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74460/1/j.1365-2559.2006.02547.x.pdf
dc.identifier.doi10.1111/j.1365-2559.2006.02547.xen_US
dc.identifier.sourceHistopathologyen_US
dc.identifier.citedreferenceJohnson LR. Gastrointestinal physiology. Philadelphia: Mosby 2001.en_US
dc.identifier.citedreferenceBrasitus TA, Sitrin MD. Intestinal malabsorption syndromes. Annu. Rev. Med. 1990; 41; 339 – 347.en_US
dc.identifier.citedreferenceGriffiths A, Taylor RH. Postgastrectomy pancreatic malabsorption: is there a case for intervention? Eur. J. Gastroenterol. Hepatol. 1999; 11; 231 – 237.en_US
dc.identifier.citedreferenceMaes BD, Hiele MI, Geypens BJ, Ghoos YF, Rutgeerts PJ. Gastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy. Eur. J. Clin. Invest. 1998; 28; 197 – 204.en_US
dc.identifier.citedreferenceBae JM, Park JW, Yang HK, Kim JP. Nutritional status of gastric cancer patients after total gastrectomy. World J. Surg. 1999; 23; 983 – 984.en_US
dc.identifier.citedreferenceFriess H, Bohm J, Muller MW et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am. J. Gastroenterol. 1996; 91; 341 – 347.en_US
dc.identifier.citedreferenceMeyer JH. Nutritional outcomes of gastric operations. Gastroenterol. Clin. North Am. 1994; 23; 227 – 260.en_US
dc.identifier.citedreferenceKreckler S, Dowson H, Willson P. Dumping syndrome as a complication of laparoscopic Nissen fundoplication in an adult. JSLS 2006; 10; 94 – 96.en_US
dc.identifier.citedreferenceAbell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am. J. Med. Sci. 2006; 331; 214 – 218.en_US
dc.identifier.citedreferenceConnor F. Gastrointestinal complications of fundoplication. Curr. Gastroenterol. Report 2005; 7; 219 – 226.en_US
dc.identifier.citedreferenceGilger MA, Yeh C, Chiang J, Dietrich C, Brandt ML, El-Seraq HB. Outcomes of surgical fundoplication in children. Clin. Gastroenterol. Hepatol. 2004; 2; 978 – 984.en_US
dc.identifier.citedreferenceUkleja A. Dumping syndrome: pathophysiology and treatment. Nutr. Clin. Pract. 2005; 20; 517 – 525.en_US
dc.identifier.citedreferenceBouras EP, Scolapio JS. Gastric motility disorders: management that optimizes nutritional status. J. Clin. Gastroenterol. 2004; 38; 549 – 557.en_US
dc.identifier.citedreferenceSaito A, Noguchi Y, Yoshikawa T et al. Gastrectomized patients are in a state of chronic protein malnutrition: analyses of 23 amino acids. Hepatogastroenterology 2001; 48; 585 – 589.en_US
dc.identifier.citedreferenceWenig BM, Heffess CS. Inflammatory, infectious, and other non-neoplastic disorders of the pancreas. In Odze RD, Goldblum JR, Crawford JM eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philidelphia: Saunders 2004; 673 – 697.en_US
dc.identifier.citedreferenceLankisch PG. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis. Digestion 1993; 54 ( Suppl. 2 ); 21 – 29.en_US
dc.identifier.citedreferenceBruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am. J. Gastroenterol. 1995; 90; 1383 – 1393.en_US
dc.identifier.citedreferenceDimagno MJ, Dimagno EP. Chronic pancreatitis. Curr. Opin. Gastroenterol. 2006; 22; 487 – 497.en_US
dc.identifier.citedreferenceLittlewood JM, Wolfe SP, Conway SP. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr. Pulmonol. 2006; 41; 35 – 49.en_US
dc.identifier.citedreferenceBayless TM, Christopher NL. Disaccharidase deficiency. Am. J. Clin. Nutr. 1969; 22; 181 – 190.en_US
dc.identifier.citedreferenceMontalto M, Curigliano V, Santoro L et al. Management and treatment of lactose malabsorption. World J. Gastroenterol. 2006; 12; 187 – 191.en_US
dc.identifier.citedreferenceTroelsen JT. Adult-type hypolactasia and regulation of lactase expression. Biochim. Biophys. Acta 2005; 1723; 19 – 32.en_US
dc.identifier.citedreferenceAuricchio S. Genetically determeined disaccharidase deficiencies. In Walker WA, Durie PR, Hamilton JR et al. eds Pediatric gastrointestinal disease. Philadelphia and Toronto: Decker 1991; 647.en_US
dc.identifier.citedreferenceWang Y, Harvey CB, Hollox EJ et al. The genetically programmed down-regulation of lactase in children. Gastroenterology 1998; 114; 1230 – 1236.en_US
dc.identifier.citedreferenceRobayo-Torres CC, Quezada-Calvillo R, Nichols BL. Disaccharide digestion: clinical and molecular aspects. Clin. Gastroenterol. Hepatol. 2006; 4; 276 – 287.en_US
dc.identifier.citedreferenceMaiuri L, Rossi M, Raia V, Paparo F, Garipoli V, Aurrichio S. Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia. Gastroenterology 1993; 105; 708 – 714.en_US
dc.identifier.citedreferenceDay DW, Jass JR, Price AB et al. Morson and Dawson's gastrointestinal pathology. Malden, MA: Blackwell 2003.en_US
dc.identifier.citedreferenceFarrell RJ, Kelly CP. Celiac sprue. N. Engl. J. Med. 2002; 346; 180 – 188.en_US
dc.identifier.citedreferenceChand N, Anastasios AM. Celiac disease: current concepts in diagnosis and treatment. J. Clin. Gastroenterol. 2006; 40; 3 – 14.en_US
dc.identifier.citedreferenceHoldstock G, Eade DE, Isaacson P, Smith CL. Endoscopic duodenal biopsy in celiac disease and duodenitis. Scand. J. Gastroenterol. 1979; 14; 717 – 720.en_US
dc.identifier.citedreferenceCollin P. New diagnostic findings in celiac disease. Ann. Med. 1999; 31; 399 – 405.en_US
dc.identifier.citedreferenceAntonioli DA. Celiac disease: a progress report. Mod. Pathol. 2003; 16; 342 – 346.en_US
dc.identifier.citedreferenceBaer AX, Bayless TM, Yardley JH. Intestinal ulceration and malabsorption syndromes. Gastroenterology 1980; 79; 754 – 765.en_US
dc.identifier.citedreferenceCatassi C, Fabiani E. The spectrum of celiac disease in children. Baillieres Clin. Gastroenterol. 1997; 11; 485 – 507.en_US
dc.identifier.citedreferenceCorazza GR, Gasbarrini G. Coeliac disease in adults. Baillieres Clin. Gastroenterol. 1995; 9; 329 – 350.en_US
dc.identifier.citedreferenceGreen PHR. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005; 128; S74 – S78.en_US
dc.identifier.citedreferenceFasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120; 636 – 651.en_US
dc.identifier.citedreferenceFarstad IN, Johansen F-E, Vlatkovic L et al. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut 2002; 51; 372 – 378.en_US
dc.identifier.citedreferenceMahadeva S, Wyatt JI, Howdle PD. Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant? J. Clin. Pathol. 2002; 55; 424 – 428.en_US
dc.identifier.citedreferenceGoldstein NS. Proximal small-bowel mucosal villous intraepithelial lymphocytes. Histopathology 2004; 44; 199 – 205.en_US
dc.identifier.citedreferenceChang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS 2005; 113; 385 – 399.en_US
dc.identifier.citedreferenceKakar S, Nehra V, Murray JA, Dayharsh GA, Burgart LJ. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am. J. Gastroenterol. 2003; 98; 2027 – 2033.en_US
dc.identifier.citedreferenceRubin CE, Brandborg LL, Phelps PC, Taylor HC Jr. Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology 1968; 54 ( Suppl. ); 800 – 802.en_US
dc.identifier.citedreferenceOberhuber G. Histopathology of celiac disease. Biomed. Pharmacother. 2000; 54; 368 – 372.en_US
dc.identifier.citedreferenceMarsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102; 330 – 354.en_US
dc.identifier.citedreferenceOberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol. 1999; 11; 1185 – 1194.en_US
dc.identifier.citedreferenceRavelli A, Bolognini S, Gambarotti M, Villanacci V. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am. J. Gastroenterol. 2005; 100; 177 – 185.en_US
dc.identifier.citedreferenceOberhuber G, Bodingbauer M, Mosberger I, Stolte M, Vogelsang H. High proportion of granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis. Am. J. Surg. Pathol. 1998; 22; 450 – 458.en_US
dc.identifier.citedreferenceCellier C, Patey N, Mauvieux L et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gatroenterology 1998; 114; 471 – 481.en_US
dc.identifier.citedreferenceVogelsang H, Oberhuber G, Wyatt J. Lymphocytic gastritis and gastric permeability in patients with celiac disease. Gastroenterology 1996; 111; 73 – 77.en_US
dc.identifier.citedreferenceBrown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch. Pathol. Lab. Med. 2006; 130; 1020 – 1025.en_US
dc.identifier.citedreferenceSchuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119; 234 – 242.en_US
dc.identifier.citedreferenceSchuppan D, Dennis MD, Kelly CP. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr. Clin. Care 2005; 8; 54 – 69.en_US
dc.identifier.citedreferenceDieterich W, Laag E, Schopper H et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115; 1317 – 1321.en_US
dc.identifier.citedreferenceSulkanen S, Halttunen T, Laurila K et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115; 1322 – 1328.en_US
dc.identifier.citedreferenceCollin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35; 1215 – 1218.en_US
dc.identifier.citedreferenceFalchuk ZM, Gebhard RL, Sessoms C, Strober W. An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture. J. Clin. Invest. 1974; 53; 487 – 500.en_US
dc.identifier.citedreferenceKatz AJ, Falchuk ZM. Definitive diagnosis of gluten-sensitive enteropathy: use of an in vitro organ culture model. Gastroenterology 1978; 75; 695 – 700.en_US
dc.identifier.citedreferenceSamloff IM, David JS, Schenk EA. A clinical and histochemical study of gluten-free diet. Gastroenterology 1965; 48; 155 – 172.en_US
dc.identifier.citedreferenceYardley JH, Bayless TM, Norton JH et al. Celiac disease: a study of the jejunal epithelium before and after a gluten-free diet. N. Engl. J. Med. 1962; 267; 1173 – 1179.en_US
dc.identifier.citedreferenceLancaster-Smith M, Packer S, Kumar PJ, Harries JT. Cellular infiltrate of the jejunum after re-introduction of dietary gluten in children with treated celiac disease. J. Clin. Pathol. 1976; 29; 587 – 591.en_US
dc.identifier.citedreferenceSollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin. Gastroenterol. Hepatol. 1999; 11; 1185 – 1194.en_US
dc.identifier.citedreferenceMacDonald WC, Dobbins WO 3rd, Rubin CE. Studies of the familial nature of celiac sprue using biopsy of the small intestine. N. Engl. J. Med. 1965; 272; 448 – 456.en_US
dc.identifier.citedreferenceHogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of celiac disease: a twenty-year follow-up study. Scand. J. Gastroenterol. 2003; 1; 61 – 65.en_US
dc.identifier.citedreferenceStenhammar L, Brandt A, Wagermark J. A family study of celiac disease. Acta Paediatr. Scand. 1982; 71; 625 – 628.en_US
dc.identifier.citedreferenceMolberg O, Mcadam SN, Korner R. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 1998; 4; 713 – 717.en_US
dc.identifier.citedreferenceLawler M, Humphries P, O'Farrelly C et al. Adenovirus E1A gene detection by polymerase chain reaction in both the normal and celiac duodenum. Gut 1994; 35; 1226 – 1232.en_US
dc.identifier.citedreferenceWeinstein WM, Saunders DR, Tytgat GN et al. Collagenous sprue—an unrecognized type of malabsorption. N. Engl. J. Med. 1970; 283; 1297 – 1301.en_US
dc.identifier.citedreferenceDaum S, Cellier C, Mulder CJJ. Refractory celiac disease. Best Prac. Res. Clin. Gastroenterol. 2005; 19; 413 – 424.en_US
dc.identifier.citedreferenceRyan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000; 119; 243 – 251.en_US
dc.identifier.citedreferenceCatassi C, Ratsch I-M, Fabian E et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343; 200 – 203.en_US
dc.identifier.citedreferenceSwinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet 1983; 1; 111 – 115.en_US
dc.identifier.citedreferenceCatassi C, Bearzi I, Holmes GKT. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005; 128; S79 – S86.en_US
dc.identifier.citedreferenceSmedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in celiac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54; 54 – 59.en_US
dc.identifier.citedreferenceCellier C, Delabesse E, Helmer C et al. Refractory sprue, celiac dieases, and enteropathy-associated T-cell lymphoma. Lancet 2000; 356; 203 – 208.en_US
dc.identifier.citedreferenceGebhard RL, Falchuk ZH, Katz SL, Sessoms C, Rogentine GN, Strober W. Dermatitis herpetiformis. Immunological concomitants of small intestinal diseases and the relationship to histocompatibility antigens. J. Clin. Invest. 1974; 54; 98 – 103.en_US
dc.identifier.citedreferenceWeinstein WM. Latent celiac sprue. Gastroenterology 1974; 66; 489.en_US
dc.identifier.citedreferenceUnsworth DJ, Leonard NL, Fry L. Antireticulin and antigliadin antibodies in dermatitis herpetiformis and celiac disease. In Beutner EH, Chorzelski TC, Kumar V eds, Chapter 25. Immunopathology of the skin, 3rd edn. New York: John Wiley & Sons Inc. 1987.en_US
dc.identifier.citedreferenceMarks J, Birkell D, Shuster S, Roberts DF. Small intestinal mucosal abnormalities in relatives of patients with dermatitis herpetiformis. Gut 1970; 11; 493 – 497.en_US
dc.identifier.citedreferenceScott BB, Young S, Rajals SM, Marks J, Losowsky MS. Coeliac disease and dermatitis herpetiformis: further studies on their relatonship. Gut 1976; 17; 759 – 762.en_US
dc.identifier.citedreferenceLoft DE, Nwokolo CU, Ciclitira PJ. The diagnosis of gluten sensitivity and celiac disease—the two are not mutually inclusive. Eur. J. Gastroenterol. Hepatol. 1998; 10; 911 – 913.en_US
dc.identifier.citedreferenceBaker SJ, Mathan VI. Syndrome of tropical sprue in India. Am. J. Clin. Nutr. 1968; 21; 984 – 993.en_US
dc.identifier.citedreferenceSchenk EA, Samloff IM, Klipstein FA. Morphologic characteristics of jejunal biopsy in celiac disease and tropical sprue. Am. J. Pathol. 1965; 47; 765 – 781.en_US
dc.identifier.citedreferenceSwanson VL, Thomassen RW. Pathology of the jejunal mucosa in tropical sprue. Am. J. Pathol. 1965; 46; 511 – 551.en_US
dc.identifier.citedreferenceWheby MS, Swanson VL, Bayless TM. Comparison of the ileal and jejunal biopsies in tropical sprue. Am. J. Clin. Nutr. 1971; 24; 117 – 123.en_US
dc.identifier.citedreferenceRobert ME. Inflammatory disorders of the small intestine. In Odze RD, Goldblum JR, Crawford JM eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philidelphia: Saunders 2004; 177 – 212.en_US
dc.identifier.citedreferenceCook GC. Aetiology and pathogenesis of postinfective tropical malabsorption (tropical sprue). Lancet 1984; 1; 721 – 723.en_US
dc.identifier.citedreferenceCook GC. Postinfective malabsorption (includes tropical sprue). In Bouchier AD, Alan RN, Hodgson JF, Deighley MRB eds. Gastroenterology. Clinical practice and science. Philadelphia: Saunders 1993; 522 – 537.en_US
dc.identifier.citedreferenceWalker MM. What is tropical sprue? J. Gastroenterol. Hepatol. 2003; 18; 887 – 890.en_US
dc.identifier.citedreferenceGhoshal UC, Ghoshal U, Ayyagari A et al. Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J. Gastroenterol. Hepatol. 2003; 18; 540 – 547.en_US
dc.identifier.citedreferenceCook GC. ‘ Tropical sprue’: some early investigators favoured an infective cause, but was a coccidian protozoan involved? Gut 1996; 39; 428 – 429.en_US
dc.identifier.citedreferenceDaum S, Sahi E, Jansen A et al. Adult autoimmune enteropathy treated successfully with tacrolimus. Digestion 2003; 68; 86 – 90.en_US
dc.identifier.citedreferenceLeon F, Olivencia P, Rodriguez-Pena R et al. Clinical and immunological features of adult-onset generalized autoimmune gut disorder. Am. J. Gastroenterol. 2005; 99; 1563 – 1571.en_US
dc.identifier.citedreferenceRusso PA, Brochu P, Seidman EG, Roy CC. Autoimmune enteropathy. Pediatr. Dev. Pathol. 1999; 2; 65 – 71.en_US
dc.identifier.citedreferenceBacchetta R., Passerini L, Gambineri E et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 2006; 116; 1713 – 1722.en_US
dc.identifier.citedreferenceLe Bras S, Geha RS. IPEX and the role of FOXP3 in the developtment and function of human Tregs. J. Clin. Invest. 2006; 116; 1473 – 1475.en_US
dc.identifier.citedreferenceRuemmele FM, Brousse N, Goulet O. Autoimmune enteropathy: molecular concepts. Curr. Opin. Gastroenterol. 2004; 20; 587 – 591.en_US
dc.identifier.citedreferenceMoore L, Xu X, Davidson G et al. Autoimmune enteropathy with anti-goblet cell antibodies. Hum. Pathol. 1995; 26; 1162 – 1168.en_US
dc.identifier.citedreferenceHori K, Fukuda Y, Tomita T et al. Intestinal goblet cell autoantibody associated enteropathy. J. Clin. Pathol. 2003; 56; 629 – 630.en_US
dc.identifier.citedreferenceWaldmann TA, Steinfeld JL, Dutcher TF et al. The role of the gastrointestinal system in ‘idiopathic hypoproteinemia. Gastroenterology 1961; 41; 197 – 207.en_US
dc.identifier.citedreferenceWaldmann TA. Protein-losing enteropathy. Gastroenterology 1966; 50; 422 – 443.en_US
dc.identifier.citedreferenceAbramowsky C, Hupertz V, Kilbridge P et al. Intestinal lymphangiectasia in children: a study of upper gastrointestinal endoscopic biopsies. Pediatr. Pathol. 1989; 9; 289 – 297.en_US
dc.identifier.citedreferenceVan Tilburg AJ, van Blankenstein M, Verschoor L. Intestinal lymphangiectasia in systemic sclerosis. Am. J. Gastroenterol. 1988; 83; 1417 – 1419.en_US
dc.identifier.citedreferenceMak K-L, Hui P-K, Chan W-Y et al. Mucosal lymphangiectasia in gastric adenocarcinoma. Arch. Pathol. Lab. Med. 1996; 120; 78 – 80.en_US
dc.identifier.citedreferenceHeresback D, Raoul J-L, Genetet N et al. Immunological study in primary intestinal lymphangiectasia. Digestion 1994; 55; 59 – 64.en_US
dc.identifier.citedreferenceFuss IJ, Strober W, Cuccherini BA et al. Intestinal lymphangiectasia, a disease characterized by selective loss of naÏve CD45RA lymphocytes into the gastrointestinal tract. Eur. J. Immunol. 1998; 28; 4275 – 4285.en_US
dc.identifier.citedreferenceAoyagi K, Iida M, Yao T et al. Characteristic endoscopic features of intestinal lymphangiectasia: correlation with histological findings. Hepatogastroenterology 1997; 44; 133 – 138.en_US
dc.identifier.citedreferenceRiemann JF, Schmidt H. Synopsis of endoscopic and other morphological findings in intestinal lymphangiectasia. Endoscopy 1981; 13; 60 – 63.en_US
dc.identifier.citedreferencePersic M, Browse NL, Prpic I. Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel resection. Arch. Dis. Child. 1998; 78; 194 – 196.en_US
dc.identifier.citedreferenceMitomi H, Atari E, Uesugi H et al. Distinctive diffuse duodenitis associated with ulcerative colitis. Dig. Dis. Sci. 1997; 42; 684 – 693.en_US
dc.identifier.citedreferenceValdez R, Appelman HD, Bronner MP, Greenson JK. Diffuse duodenitis associated with ulcerative colitis. Am. J. Surg. Pathol. 2000; 24; 1407 – 1413.en_US
dc.identifier.citedreferenceSasaki M, Okada K, Koyama S et al. Ulcerative colitis complicated by gastroduodenal lesions. J. Gastroenterol. 1996; 31; 585 – 589.en_US
dc.identifier.citedreferenceSjogren RW. Gastrointestinal features of scleroderma. Curr. Opin. Rheumatol. 1996; 8; 569 – 575.en_US
dc.identifier.citedreferenceYoung MA, Rose S, Reynolds JC. Gastrointestinal manifestations of scleroderma. Rheum. Dis. Clin. North Am. 1996; 22; 797 – 823.en_US
dc.identifier.citedreferenceSjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994; 37; 1265 – 1282.en_US
dc.identifier.citedreferenceAment ME, Shimoda SS, Saunders DP, Rubin CE. Pathogenesis of steatorrhea in three cases of small intestinal stasis syndrome. Gastroenterology 1972; 63; 728 – 747.en_US
dc.identifier.citedreferenceGianella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind-loop syndrome. Gastroenterology 1974; 67; 965 – 974.en_US
dc.identifier.citedreferenceGoldstein F. Mechanisms of malabsorption and malnutrition in the blind-loop syndrome. Gastroenterology 1971; 61; 780 – 784.en_US
dc.identifier.citedreferenceKaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Black CM. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br. J. Rheumatol. 1995; 34; 265 – 269.en_US
dc.identifier.citedreferenceKrishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93; 610 – 639.en_US
dc.identifier.citedreferenceSchuffler MD, Beegle RG. Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle. Gastroenterology 1979; 77; 664 – 671.en_US
dc.identifier.citedreferenceAment ME, Ochs HD, Davis SD. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes: a study of 39 patients. Medicine 1973; 52; 227 – 248.en_US
dc.identifier.citedreferenceAment ME. Immunodeficiency syndromes and the gut. Scand. J. Gastroenterol. Suppl. 1985; 114; 127 – 135.en_US
dc.identifier.citedreferenceAment ME, Rubin CE. Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes. Gastroenterology 1972; 62; 216 – 226.en_US
dc.identifier.citedreferenceKagnoff MF. Immunology and inflammation of the gastrointestinal tract. In Sleisinger MH, Fordtran JS eds. Gastrointestinal disease, 5th edn. Philadelphia: Saunders 1993; 45 – 86.en_US
dc.identifier.citedreferenceNagura H, Kohler PF, Brown WR. Immunocytochemical characterization of the lymphocytes in nodular lymphoid hyperplasia of the bowel. Lab. Invest 1979; 40; 66 – 73.en_US
dc.identifier.citedreferenceTytgat GN, Huibregtse K, Schellekens PTA, Feltkamp-Vroom TH. Clinical and immunologic observations in a patient with late onset immunodeficiency. Gastroenterology 1979; 76; 1458 – 1465.en_US
dc.identifier.citedreferenceYardley JH, Hendrix TR. Immunologic status in patients with giardiasis. Gastroenterology 1980; 78; 421 – 422.en_US
dc.identifier.citedreferenceCunningham-Rundles C. Clinical and immunologic analysis of 103 patients with common variable immunodeficiency. J. Clin. Immunol. 1989; 9; 22 – 33.en_US
dc.identifier.citedreferenceGillin JS, Shike M, Alcock N et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann. Intern. Med. 1985; 102; 619 – 622.en_US
dc.identifier.citedreferenceKotler D, Gaetz H, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 1984; 101; 421 – 428.en_US
dc.identifier.citedreferenceKotler DP. Human immunodeficiency virus-related wasting: malabsorption syndromes. Semin. Oncol. 1998; 25 ( 2 Suppl. 6 ); 70 – 75.en_US
dc.identifier.citedreferenceGreenson JK, Belitsos PC, Yardley JH, Bartlett JG. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann. Intern. Med. 1991; 114; 366 – 372.en_US
dc.identifier.citedreferenceLaughon BE, Druckman DA, Vernon A et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988; 94; 984 – 993.en_US
dc.identifier.citedreferenceSmith PD, Lane HC, Gill VJ et al. Intestinal infection in patients with the acquired immunodeficiency syndrome (AIDS): etiology and response to therapy. Ann. Intern. Med. 1988; 108; 433 – 438.en_US
dc.identifier.citedreferenceKotler DP, Orenstein JM. Chronic diarrhea and malabsorption associated with enteropathogenic bacterial infection in a patient with AIDS. Ann. Intern. Med. 1993; 119; 127 – 128.en_US
dc.identifier.citedreferenceEeftinck-Schattenkerk JK, van Gool T, van Ketal RJ et al. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 1991; 337; 895 – 898.en_US
dc.identifier.citedreferenceYan Z, Nguyen S, Poles M, Melamed J, Scholes JV. Adenovirus colitis in human immunodeficiency virus infection: an underdiagnosed entity. Am. J. Surg. Pathol. 1998; 22; 1101 – 1106.en_US
dc.identifier.citedreferenceUkarapol N, Chartapisak W, Lertprasertsuk N et al. Cytomegalovirus-associated manifestation involving the digestive tract in children with human immunodeficiency virus infection. J. Pediatr. Gastroenterol. Nutr. 2002; 35; 669 – 673.en_US
dc.identifier.citedreferenceBatman PA, Miller ARO, Forster SM, Harris JRW, Pinching AJ, Griffin GE. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitiative histology. J. Clin. Pathol. 1989; 42; 275 – 281.en_US
dc.identifier.citedreferenceCummins AG, Labrooy JT, Stanley DP, Rowland R, Shearman DJC. Quantitative histological study of enteropathy associated with HIV infection. Gut 1990; 31; 317 – 321.en_US
dc.identifier.citedreferenceMiller AR, Griffin GE, Batman P et al. Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus. Q. J. Med. 1988; 69; 1009 – 1019.en_US
dc.identifier.citedreferenceKapembwa MS, Batman PA, Fleming SC, Griffin GE. HIV enteropathy. Lancet 1989; 2; 1521 – 1522.en_US
dc.identifier.citedreferenceBatman PA, Kapembwa MS, Griffin GE. Enteropathy associated with HIV. Gut 1990; 31; 960.en_US
dc.identifier.citedreferenceRotterdam H, Sommers SC. Alimentary tract biopsy lesions in the acquired immune deficiency syndrome. Pathology 1985; 17; 181 – 192.en_US
dc.identifier.citedreferenceBudhraja M, Levendoglu H, Kocka F, Mangkomkanok M, Sherer R. Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am. J. Gastroenterol. 1987; 82; 427 – 431.en_US
dc.identifier.citedreferenceEllakany S, Whiteside TL, Schade RR, van Thiel DH. Analysis of intestinal lymphocyte subpopulations in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am. J. Clin. Pathol. 1987; 87; 356 – 364.en_US
dc.identifier.citedreferenceRodgers VD, Fassett R, Kagnoff MF. Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome. Gastroenterology 1986; 90; 552 – 558.en_US
dc.identifier.citedreferenceRodgers VD, Kagnoff MF. Abnormalities of the intestinal immune system in AIDS. Gastroenterol. Clin. North Am. 1988; 17; 487 – 494.en_US
dc.identifier.citedreferenceWeber JR, Dobbins WO 3rd. The intestinal and rectal epithelial lymphocyte in AIDS: an electron-microscopic study. Am. J. Surg. Pathol. 1986; 10; 627 – 639.en_US
dc.identifier.citedreferenceSnijders F, Heenan J, van den Blink B, van Deventer SJ, ten Kate FJ. Duodenal intraepithelial and lamina propria T lymphocytes in human immunodeficiency virus-infected patients with and without diarrhoea. Scand. J. Gastroenterol. 1996; 31; 1176 – 1181.en_US
dc.identifier.citedreferenceGuadalupe M, Reay E, Sandaran S et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003; 77; 11709 – 11717.en_US
dc.identifier.citedreferenceHarriman GR, Smith PD, Horne MK et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 1989; 149; 2039 – 2041.en_US
dc.identifier.citedreferenceHerzlich BC, Schiano TD. Reversal of apparent AIDS dementia complex following treatment with vitamin B12. J. Intern. Med. 1993; 233; 495 – 497.en_US
dc.identifier.citedreferenceDworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem. Biol. Interact. 1994; 91; 181 – 186.en_US
dc.identifier.citedreferenceEhrenpreis ED, Carlson SJ, Boorstein HL, Craig RM. Malabsorption and deficiency if vitamin B12 in HIV-infected patients with chronic diarrhea. Dig. Dis. Sci. 1994; 31; 2159 – 2162.en_US
dc.identifier.citedreferenceTaylor C, Hodgson K, Sharpstone D et al. The prevalence and severity of intestinal disaccharidase deficiency in human immunodeficiency virus-infected subjects. Scand. J. Gastroenterol. 2000; 35; 599 – 606.en_US
dc.identifier.citedreferenceFox CH, Kotler D, Tierney A, Wilson CS, Fauci AS. Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. J. Infect. Dis. 1989; 159; 467 – 471.en_US
dc.identifier.citedreferenceJarry A, Cortez A, Rene E, Muzeau F, Brousse N. Infected cells and immune cells in the gastrointestinal tract of AIDS patients: an immunohistochemical study of 127 cases. Histopathology 1990; 16; 133 – 140.en_US
dc.identifier.citedreferenceModigliani R, Bodes C, Charpentier YL et al. Diarrhoea and malabsorption in acquired immune deficiency syndrome: a study of four cases with special emphasis on opportunistic protozoan infestations. Gut 1985; 26; 179 – 187.en_US
dc.identifier.citedreferenceUllrich R, Zeitz M, Heise W, L’age M, Hoffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann. Intern. Med. 1989; 111; 15 – 21.en_US
dc.identifier.citedreferenceZeitz M, Ullrich R, Schneider T, Kewenig S, Hohloch K, Riecken EO. HIV/SIV enteropathy. Ann. NY Acad. Sci. 1998; 859; 139 – 148.en_US
dc.identifier.citedreferenceNannini EC, Okhuysen PC. HIV1 and the gut in the era of highly active antiretroviral therapy. Curr. Gastroenterol. Report 2002; 4; 392 – 398.en_US
dc.identifier.citedreferenceQuigley EMM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130; S78 – S90.en_US
dc.identifier.citedreferenceHusebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2006; 51 ( Suppl. 1 ); 1 – 22.en_US
dc.identifier.citedreferenceGhoshal U, Ghoshal UC, Ranjan P, Naik SR, Ayyagary A. Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol. 2003; 3; 9.en_US
dc.identifier.citedreferenceBouhnik Y, Alain S, Attar A et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am. J. Gastroenterol. 1999; 94; 1327 – 1331.en_US
dc.identifier.citedreferenceMitsui T, Shimaoka K, Goto Y et al. Small bowel bacterial overgrowth is not seen in healthy adults but is in disabled older adults. Hepatogastroenterology 2006; 53; 82 – 85.en_US
dc.identifier.citedreferenceTeo M, Chung S, Chitti L et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J. Gastroenterol. Hepatol. 2004; 19; 904 – 909.en_US
dc.identifier.citedreferenceHaboubi NY, Lee GS, Montgomery RD. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. Age Ageing 1991; 20; 29 – 32.en_US
dc.identifier.citedreferenceRiordan SM, McIver CJ, Wakefield D, Duncombe VM, Thomas MC, Bolin TD. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am. J. Gastroenterol. 2001; 96; 494 – 500.en_US
dc.identifier.citedreferenceJonas A, Krishnan C, Forstner G. Pathogenesis of mucosal injury in the blind loop syndrome. Gastroenterology 1978; 75; 791 – 795.en_US
dc.identifier.citedreferenceToskes PP, Giannella RA, Jervis HR, Rout WR, Takeuchi A. Small intestinal mucosal injury in the experimental blind loop syndrome. Light- and electron-microscopic and histochemical studies. Gastroenterology 1975; 68; 1193 – 1203.en_US
dc.identifier.citedreferenceMathias JR, Clench MH. Review: pathophysiology of diarrhea caused by bacterial overgrowth of the small intestine. Am. J. Med. Sci. 1985; 289; 243 – 248.en_US
dc.identifier.citedreferenceRiordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC. Luminal antigliadin antibodies in small intestinal bacterial overgrowth. Am. J. Gastroenterol. 1997; 92; 1335 – 1338.en_US
dc.identifier.citedreferenceWhipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull. Johns Hopkins Hosp. 1907; 18; 382 – 391.en_US
dc.identifier.citedreferenceDutly F, Altwegg M. Whipple's disease and ‘ Tropheryma whippelii ’. Clin. Microbiol. Rev. 2001; 14; 561 – 583.en_US
dc.identifier.citedreferenceMarth T, Raoult D. Whipple's disease. Lancet 2003; 361; 239 – 246.en_US
dc.identifier.citedreferenceBai JC, Mazure RM, Vazquez H et al. Whipple's disease. Clin. Gastroenterol. Hepatol. 2004; 2; 849 – 860.en_US
dc.identifier.citedreferenceMuir-Padilla J, Myers JB. Whipple disease: a case report and review of the literature. Arch. Pathol. Lab. Med. 2005; 129; 933 – 936.en_US
dc.identifier.citedreferenceMonkemuller K, Fry LC, Rickes S, Malfertheiner P. Whipple's disease. Curr. Infect. Dis. Report 2006; 8; 96 – 102.en_US
dc.identifier.citedreferenceRaoult D, Birg ML, La Scola B et al. Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 2000; 342; 620 – 625.en_US
dc.identifier.citedreferenceMisbah SA, Mapstone NP. Whipple's disease revisited. J. Clin. Pathol. 2000; 53; 750 – 755.en_US
dc.identifier.citedreferenceMisbah SA, Aslam A, Costello C. Whipple's disease. Lancet 2004; 363; 654 – 656.en_US
dc.identifier.citedreferenceBassotti G, Pelli MA, Ribacchi R. et al. Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am. J. Gastroenterol. 1991; 86; 371 – 374.en_US
dc.identifier.citedreferenceGil Ruiz JA, Gil Simon P, Aparicio Duque R, Mayor Jerez JL. Association between Whipple's disease and Giardia lamblia infection. Rev. Esp. Enferm. Dig. 2005; 97; 521 – 526.en_US
dc.identifier.citedreferenceDesnues B, Ihrig M, Raoult D, Mege J-L. Whipple's disease: a macrophage disease. Clin. Vaccine Immunol. 2006; 13; 170 – 178.en_US
dc.identifier.citedreferenceKuhajda FP, Belitsos NJ, Keren DF, Hutchins GM. A submucosal variant of Whipple's disease. Gastroenterology 1982; 82; 46 – 50.en_US
dc.identifier.citedreferenceGillin JS, Urmacher C, West R, Shike M. Disseminated Mycobacterium avium-intercellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology 1983; 85; 1187 – 1191.en_US
dc.identifier.citedreferenceMcCullough K, Damjanov I. Intestinal histoplasmosis mimicking Whipple's disease. Histopathology 2006; 48; 306 – 323.en_US
dc.identifier.citedreferenceWolfe MS. Giardiasis. Clin. Microbiol. Rev. 1992; 5; 93 – 100.en_US
dc.identifier.citedreferencePhillips SC, Mildvan D, William DC, Gelb AM, White MC. Sexual transmission of enteric protozoa and helminths in a venereal-disease-clinic population. N. Engl. J. Med. 1981; 305; 603 – 606.en_US
dc.identifier.citedreferenceda Silva JR, Coutinho SG, Dias LB, de Figueiredo N. Histopathologic findings in giardiasis: a biopsy study. Am. J. Dig. Dis. 1964; 10; 355 – 365.en_US
dc.identifier.citedreferenceSun T. The diagnosis of giardiasis. Am. J. Surg. Pathol. 1980; 4; 265 – 271.en_US
dc.identifier.citedreferenceOberhuber G, Kastner N, Stolte M. Giardiasis: a histologic analysis of 567 cases. Scand. J. Gastroenterol. 1997; 32; 48 – 51.en_US
dc.identifier.citedreferenceLevinson JD, Nastro LJ. Giardiasis with total villous atrophy. Gastroenterology 1978; 74; 271 – 275.en_US
dc.identifier.citedreferenceCurrent WL, Reese NC, Ernst JV, Bailey WS, Heyman MB, Weinstein WM. Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N. Engl. J. Med. 1983; 308; 1252 – 1257.en_US
dc.identifier.citedreferenceMeisel JL, Perera DR, Meligro C, Rubin CE. Overwhelming watery diarrhea associated with Cryptosporidium in an immunocompromised patient. Gastroenterology 1978; 70; 1156 – 1160.en_US
dc.identifier.citedreferenceMacKenzie WR, Hoxie NJ, Proctor ME et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 1994; 331; 161 – 167.en_US
dc.identifier.citedreferenceChappell CL, Okhuysen PC. Cryptosporidiosis. Curr. Opin. Infect. Dis. 2002; 15; 523 – 527.en_US
dc.identifier.citedreferenceHunter PR, Thompson RCA. The zoonotic transmission of Giardia and Cryptosporidium. Int. J. Parasitol. 2005; 35; 1181 – 1190.en_US
dc.identifier.citedreferenceJessurun J, Pambuccian S. Infectious and inflammatory disorders of the gallbladder and extrahepatic biliary tract. In Odze RD, Goldblum JR, Crawford JM eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philidelphia: Saunders 2004; 609 – 638.en_US
dc.identifier.citedreferenceKeeling PJ, Fast NM. Microsporidia: biology and evolution of highly reduced intracellular parasites. Annu. Rev. Microbiol. 2002; 56; 93 – 116.en_US
dc.identifier.citedreferenceOrenstein JM, Chiang J, Steinberg W, Smith PD, Rotterdam H, Kotler DP. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients. Hum. Pathol. 1990; 21; 475 – 481.en_US
dc.identifier.citedreferenceAsmuth DM, DeGirolami PC, Federman M et al. Clinical features of microsporidiosis in patients with AIDS. Clin. Infect. Dis. 1994; 18; 819 – 825.en_US
dc.identifier.citedreferencevan Gool T, Hollister WS, Schattenkerk JE et al. Diagnosis of Enterocytozoon bieneusi microsporidiosis in AIDS patients by recovery of spores from faeces. Lancet 1990; 336; 697 – 698.en_US
dc.identifier.citedreferenceOrenstein JM, Zierdt W, Zierdt C, Kotler DP. Identification of spores of Enteroctyozoon bieneusi in stool and duodenal fluid from AIDS patients. Lancet 1990; 336; 1127 – 1128.en_US
dc.identifier.citedreferenceRabeneck L, Gyorkey F, Genta RM, Gyorkey P, Foote LW, Risser JM. The role of microsporidia in the pathogenesis of HIV-related chronic diarrhea. Ann. Intern. Med. 1993; 119; 895 – 899.en_US
dc.identifier.citedreferencevan Gool T, Canning EU, Gillis H, van den Bergh-Weerman MA, Eeftinck-Schattenkerk JK, Dankert J. Septata intestinalis frequently isolated from stool of AIDS patients with a new cultivation method. Parasitology 1994; 109; 281 – 289.en_US
dc.identifier.citedreferenceFranzen C, Muller A. Microsporidiosis: human diseases and diagnosis. Microbes Infect. 2001; 3; 389 – 400.en_US
dc.identifier.citedreferenceWeber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. N. Engl. J. Med. 1992; 326; 161 – 166.en_US
dc.identifier.citedreferenceGiang TT, Kotler DP, Garro ML, Orenstein JM. Tissue diagnosis of intestinal microsporidiosis using the chromotrope-2R modified trichrome stain. Arch. Pathol. Lab. Med. 1993; 117; 1249 – 1251.en_US
dc.identifier.citedreferenceSobottka I, Schwartz DA, Schottelius J et al. Prevalence and clinical significance of intestinal microsporidiosis in human immunodeficiency virus-infected patients with and without diarrhea in Germany: a prospective coprodiagnostic study. Clin. Infect. Dis. 1998; 26; 475 – 480.en_US
dc.identifier.citedreferenceOrenstein JM. Diagnostic pathology of microsporidiosis. Ultrastruct. Pathol. 2003; 27; 141 – 149.en_US
dc.identifier.citedreferenceConteas CN, Berlin OG, Ash LR, Pruthi JS. Therapy for human gastrointestinal microsporidiosis. Am. J. Trop. Med. Hyg. 2000; 63; 121 – 127.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.